- Home
- FTAI vs ICLR Comparison
FTAI vs ICLR Comparison
Compare FTAI & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FTAI | ICLR |
|---|---|---|
| Founded | 2011 | 1990 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Misc Corporate Leasing Services | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.8B | 15.1B |
| IPO Year | 2015 | 1998 |
Fundamental Metrics
Financial Performance| Metric | FTAI | ICLR |
|---|---|---|
| Price | $273.01 | $185.42 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 14 |
| Target Price | ★ $221.25 | $201.46 |
| AVG Volume (30 Days) | ★ 1.6M | 944.0K |
| Earning Date | 02-25-2026 | 02-18-2026 |
| Dividend Yield | ★ 0.51% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | 4.36 | ★ 7.47 |
| Revenue | $2,344,200,000.00 | ★ $8,102,602,000.00 |
| Revenue This Year | $50.04 | N/A |
| Revenue Next Year | $26.58 | $0.39 |
| P/E Ratio | $62.76 | ★ $24.43 |
| Revenue Growth | ★ 51.35 | N/A |
| 52 Week Low | $75.06 | $125.10 |
| 52 Week High | $277.07 | $211.00 |
Technical Indicators
Market Signals| Indicator | FTAI | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 83.44 | 51.01 |
| Support Level | $228.18 | $179.54 |
| Resistance Level | $257.69 | $185.99 |
| Average True Range (ATR) | 13.39 | 6.84 |
| MACD | 5.58 | -1.03 |
| Stochastic Oscillator | 96.65 | 41.24 |
Price Performance
Historical ComparisonAbout FTAI FTAI Aviation Ltd.
FTAI Aviation Ltd is an aerospace company. It owns and maintains commercial jet engines with a focus on CFM56 engines. FTAI owns and leases jet aircraft, which often facilitates the acquisition of engines at attractive prices. It invests in aviation assets and aerospace products that generate stable cash flows with the potential for earnings growth and asset appreciation.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.